Bispecific antibodies are able to bind simultaneously to two separate unique antigens, or even epitopes of the same antigen. One of the most widely used applications for this tool is in the study and development of cancer immunotherapies.
InvivoGen offers bispecific antibodies consisting of single chain variable fragments (scFvs) from two different monoclonal antibodies joined by a glycine-serine linker. Negative controls for the bispecific antibodies with E. coli β-galactosidase specificity for both binding site are also available.
InvivoGen’s bispecific antibodies are generated in mammalian CHO cells and are guaranteed to be free of bacterial contamination.